On the other hand, Mariniello A, et al. described transformation to a squamous histology phenotype in a patient with an initial adenocarcinoma carrying a non-V600 BRAF mutation under immunotherapy (anti-PD-L1). This evidence concerns the gene BRAF and adenocarcinoma.